Vânia M. Alcântara, Lisangela C. Oliveira, Rosângela R. Réa, Henrique L. Suplicy, Eleidi A. Chautard-Freire-Maia
Butyrylcholinesterase activity and metabolic syndrome in obese patients
Total butyrylcholinesterase activity (EC 3.1.1.8) was previously suggested as a marker for metabolic syndrome. The present study examined total butyrylcholinesterase activity and the relative and absolute activities of two butyrylcholinesterase electrophoretic bands (C
4/5 and C
OF) in 99 obese individuals (body mass index ?30 kg/m
2) presenting the CHE2 C5
? phenotype of the
CHE2 gene. Anthropometric, hormonal and biochemical variables already associated with metabolic syndrome were also examined. The data from these obese individuals of the CHE2 C5? phenotype show that total butyrylcholinesterase activity and the absolute activities of the C
4/5 and C
OF electrophoretic bands are associated with metabolic syndrome and with variables related to it. These butyrylcholinesterase activities do not behave as independent risk factors for metabolic syndrome, but can be considered as secondary markers for this syndrome in obese individuals with the CHE2 C5? phenotype.
Clinical Chemical Laboratory Medicine, Walter de Gruyter
Print ISSN: 1434-6621
Volume: 43, 03/2005
Pages: 285 - 288
Show full article (external site)
Show all available items of this journal